Exchange: NYSE·Updated 05:51 PM EDT
CRL logo

CRLCharles River Laboratories International Inc.

$230.69
$1.60
(0.70%)
Today
Closed $230.69
$0.00
(0.00%)
After Hours
EarningsAug 5
Mkt Cap$11.11B
Vol845,345.00
News
all
press releases
Why is Morgan Stanley Bullish on Charles River Laboratories International, Inc. (CRL) as a Top Stock to Buy According to Ariel Investment?
Why is Morgan Stanley Bullish on Charles River Laboratories International, Inc. (CRL) as a Top Stock to Buy According to Ariel Investment...
Yahoo! Finance: News
News Placeholder
More News
News Placeholder
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026 Shareholders are encouraged to contact the firm to...
PR Newswire
News Placeholder
LH or CRL: Which Is the Better Value Stock Right Now?
LH vs. CRL: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Is This the Right Time to Hold CRL Stock in Your Portfolio?
Charles River leans on RMS strength, CRADL adoption and portfolio moves. Can these offset soft biopharma demand and currency headwinds?
Zacks
News Placeholder
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab was created to accelerate biotech innovation by enabling participating companies to access AI/ML...
Business Wire
News Placeholder
LH vs. CRL: Which Stock Is the Better Value Option?
LH vs. CRL: Which Stock Is the Better Value Option?
Zacks
News Placeholder
CRL Crosses Below Key Moving Average Level
In trading on Tuesday, shares of Charles River Laboratories International Inc. (Symbol: CRL) crossed below their 200 day moving average of $176.42, changing hands as low as $172.17 per share. Charles River Laboratories International Inc. shares are currently trading down about...
Nasdaq News: Markets
News Placeholder
Charles River Laboratories to Present at William Blair and Jefferies Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2nd, at 10:00 a.m. CT (11:00 a.m. ET), and at the Jefferies Global Healthcare Conference on Wednesday, June 3rd, at 9:55 a.m. ET...
Business Wire
News Placeholder
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well...
Business Wire
<
1
2
...
>

Advertisement|Remove ads.